Four Tips for Dealing With an Extended Market<br />By Rev Shark<br />RealMoney.com Contributor<br />7/28/2009 8:58 AM EDT <br /><br />I don't look to jump over 7-foot bars; I look around for 1-foot bars that I can step over. <br />-- Warren Buffett<br /><br />It is impossible to sit down, look at the market action over the last couple weeks and think, "I really want to make a lot of big aggressive buys right now." The straight-up move in this market is practically unprecedented, and we are extended and overbought by nearly any measure you might employ. That doesn't mean that we still don't have some momentum, and there is nothing to indicate that a major pullback is about to occur. <br /><br />The great difficulty is that even my 4-year-old son can spot the overbought stochastics. Is there anyone who isn't aware of the fact that this market could use a rest? We all know that things are a bit too elevated, but we also know that the market may continue to act in this gravity-defying way for a while and not pull back very much. <br /><br />The great anxiety for many isn't that they will be caught too long in an extended market, but that they won't be long enough when the extended market keeps on becoming even more extended. Those who have been trying to jump in on a market pullback are increasingly likely to just pay up so they don't have to sit on the sidelines with too much idle cash for longer. <br /><br />How do we deal with this market that is obviously quite extended but is showing no signs of pulling back? <br /><br />1. Don't expect a sudden and complete collapse. Markets that go up as aggressively as this one has don't just reverse on a dime and go back down. They stay sticky to the upside and will often only have shallow pullbacks that attract quick dip-buyers. Don't be overly aggressive with shorts until some real weakness begins to set in. <br /><br />2. Don't throw your discipline aside. In a market this extended, you are not going to find many charts that are set up well in strong bases. There are some -- you'll have to work to find them, but they are out there. The important thing is to not just chase anything that is moving out of frustration over being left behind. Make sure you have a plan of attack in mind. If you buy a stock that is up five, six or seven days in a row, make sure you have a exit strategy in mind as well. <br /><br />3. Stay patient. It can be frustrating to see the market rack up some huge percentage moves and hear the folks yell and shout about how great it all is while you were holding high levels of cash. The important thing isn't to dwell on where we have been; focus on what we are going to do next. Don't let the emotions affect you. Stay focused on finding good trades where you can control your risk. <br /><br />4. Keep on digging. Even in a tremendously extended market, you can find opportunities. The key is to identify the themes that are starting to work and try to catch them as they gain further attention. They can shift very fast, but the hot-money traders will always be looking for something new, and if you can find it early you can knock out some trades ... even in a market that is painfully in need of some consolidation. <br /><br />We have a little selling this morning, but noting too aggressive. The earnings reports that are trickling in continue to be mostly positive and there isn't any major news moving us. <br />--------------------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: LCRD +25.3%, VECO +15.9% (also upgraded to Buy at Citigroup), AMED +13.9%, PCX +9.7%, EVVV +9.7%, ENOC +9.4% (also upgraded to Buy at Jefferies), SOA +8.8%, QLTI +8.6%, THC +8.3%, UIS +7.6%, SFSF +7.4%, UA +7.3%, MAS +6.9%, BWLD +5.1%, CVH +4.7% (light volume), HMA +4.7%, FDP +3.5%, AMGN +3.4%, RCII +3.3%, FNF +3.2%, BBV +3.1% (light volume), CHKP +3.0%, CF +2.6%... M&A news: SPSS +40.2% (IBM to acquire co for $50/share in cash), VM +24.7% (Sprint Nextel to acquire Virgin Mobile USA; public shareholders to receive $5.50/share )... Other news: ARIA +33.5% (announces preliminary data from two ongoing clinical trials of its investigational mTOR inhibitor, Ridaforolimus, in combination with targeted drugs), MRX +10.0% (announces approval of new strengths of SOLODYN; also upgraded to Outperform at RBC Capital Mkts), VICL +7.1% (receives $10 mln investment from Federated Kaufmann Funds; also to sell 2.8 mln common shares to Federated Kaufmann at $3.63/share in registered direct offering), SCLN +6.3% (expands portfolio by licensing Ondansetron RapidFilmfor Chinese market), TTM +4.9% (still checking)... Analyst comments: SNY +1.8% (upgraded to Overweight at Morgan Stanley), ADSK +1.5% (upgraded to Buy at Jefferies). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ODP -16.8%, IPG -12.0%, TRID -11.9%, DB -9.2% (also downgraded to Neutral from Buy at UBS), COH -6.8%, AME -6.7%, JEC -6.5%, WAT -5.8%, OLN -5.3%, MTW -5.2%, PCAR -5.1%, PFWD -4.6% (light volume), X -3.8%, VLO -2.5%, TSL -2.2% (also files mixed-securities shelf AND announces follow-on public offering of 4,000,000 American Depositary Shares), GOLD -1.9%... Select financials showing weakness: ING -4.3%, AEG -4.2%, UBS -3.3%, RBS -3.3% (Royal Bank of Scotland may back out of government lending plan - Times of London), CS -3.2% (downgraded to Underperform at FBR Capital), BCS -2.0%, AXA -2.0%, AZ -1.9%, LYG -1.8%, BAC -1.5% (BofA plans to cut 10% of branches - WSJ)... Select oil/gas stocks trading lower: WFT -2.7%, E -1.9%, RIG -1.9%, HON -1.8%, SNP -1.7%, TOT -1.2%... Select metals/mining names showing weakness: MT -4.0%, AAUK -2.6%, VALE -1.7%, BBL -1.3%... Other news: USU -48.3% (Department of Energy denies USEC's loan guarantee application; also downgraded to Hold at Jefferies), ABK -15.8% (announces Q2 estimate of credit derivative impairment and loss and loss expenses), AIXG -9.0% (still checking), MTL -6.1% (still checking), MICC -5.0% (still checking), HGSI -4.2% (announces it has commenced an 18 mln share common stock offering pursuant to a prospectus), ANR -1.5% (Duquense Capital Mgmt, ANR's largest shareholder, reconfirms it will vote against FCL merger), SQNM -1.4% (announces launch of MassARRAY Compact 96 system), ... Analyst comments: CHINA -6.8% (downgraded to Neutral at Wedbush Morgan), WGOV -6.6% (downgraded to Neutral at Baird), CERS -6.0% (downgraded to Neutral at Baird), MET -5.3% (downgraded to Neutral at BofA/Merrill), LEN -3.5% (downgraded to Hold at Citigroup), PM -1.5% (downgraded to Neutral from Buy at UBS), AXP -1.3% (cut to In line from Outperform at Fox Pitt- based on valuation), ERIC -1.2% (downgraded to Sell from Neutral at UBS).